主要胆汁酸在炎症性肠道疾病相关的原发性硬化胆管炎中塑造了外周免疫力
André A Santos1, David Pires2, Vanda Marques1
1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.
Clinical science (London, England : 1979)
|June 6, 2025
概括
初级硬化性胆道炎 (PSC) 与单独的炎症性肠病 (IBD) 相比,独特地改变了免疫反应. 在PSC患者中的胆酸促进炎症,有助于疾病的发展.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 原发性硬化性胆道炎 (PSC) 是一种慢性肝病,经常与炎症性肠病 (IBD) 一起发生.
- 与单独IBD相比,PSC的独特免疫失调仍然不完全理解.
- 研究PSC,IBD和免疫反应之间的相互作用对于理解疾病的发病过程至关重要.
研究的目的:
- 阐明PSC患者的特定炎症免疫反应,特别是那些同时患有IBD的患者.
- 将PSC患者的免疫特征与IBD患者和健康对照者的免疫特征进行比较.
- 确定潜在的机制,如胆酸参与,驱动独特的PSC表型.
主要方法:
- 一项涉及75名参与者的病例控制研究:16名患有PSC (14名患有IBD),39名仅患有IBD,20名对照.
- 对血清胆汁酸概况,血清蛋白质特征和结肠免疫相关基因表达 (mRNA) 的分析.
- 在人体单细胞与甘氨基基氧醇酸 (GCDCA) 的体外联合化,以评估炎症反应.
主要成果:
- 在PSC患者的结肠组织中,免疫调节和炎症mRNA标志物 (LGR5,IL-8,CCL2,COX2,TWIST1,SNAIL) 呈现上升.
- 脊髓炎患者表现出明显的促炎血清蛋白质特征和某些胆酸含量升高,包括GCDCA.
- 暴露于GCDCA部分模仿了PSC患者的炎症特征,这表明它在免疫调节中的作用.
结论:
- PSC与结肠组织和血清中独特的炎症特征有关,与单独的IBD不同.
- 循环胆酸,如GCDCA,可能在调节外周免疫反应和促进PSC病变发生方面发挥重要作用.
- 这些发现突出了胆酸作为潜在的治疗点来管理PSC的炎症方面.
相关概念视频
01:17Chronic Bowel Disorders: Introduction
544
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
544
01:30Inflammatory Bowel Disease II: Crohn's Disease
402
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
402
01:24Chronic Pancreatitis I: Introduction
173
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
173
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
348
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
348
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240
01:29Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244